Carole A. Long

Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Alexander D. Douglas, Andrew R. Williams, Joseph J. Illingworth et al. · Nature Communications · 2013 · 924 citations · Full text

Vaccination, Pathogenesis, Immunology +3

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Yimin Wu, Ruth D. Ellis, Donna Shaffer et al. · PLoS ONE · 2008 · 450 citations · Full text

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Alexander D. Douglas, Andrew R. Williams, Joseph J. Illingworth et al. · Nature Communications · 2011 · 277 citations · Full text

Vaccination, Pathogenesis, Immunology +4

Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for <i>Plasmodium falciparum</i> Malaria

Elissa Malkin, David Diemert, Julie H. McArthur et al. · Infection and Immunity · 2005 · 251 citations · Full text

Vaccination, Asexual Blood-stage Vaccine, Vaccine Development +14

Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines

Kazutoyo Miura, Andrew C. Orcutt, Olga Muratova et al. · Vaccine · 2007 · 242 citations · Full text

Vaccination, Standardized Elisa, Malaria +10